Allergy and Infectious Diseases Research in Minnesota
Allergy and Infectious Diseases Research (93.855) awarded $323 million to recipients in Minnesota in 228 grants from fiscal 2021 to 2025, 1.5% of the program's national total. Regents of the University of Minnesota received the most, $268 million.
- Awarded in Minnesota$323 million
- Awards228
- Share of the program1.5%
- Rank among states17th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 113 | $47.6 million |
| FY 2022 | 105 | $112 million |
| FY 2023 | 98 | $48.9 million |
| FY 2024 | 97 | $52.2 million |
| FY 2025 | 105 | $62.0 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Minnesota | Colleges and universities | 163 | $268 million |
| Mayo Clinic | Nonprofits | 49 | $42.2 million |
| Marpam Pharma LLC | Small businesses | 5 | $5.1 million |
| Hennepin Healthcare Research Institute | Nonprofits | 7 | $4.4 million |
| National Marrow Donor Program | Nonprofits | 1 | $2.1 million |
| Gavia Bio, LLC | Small businesses | 1 | $314,363 |
| Kommodo Holdings Corp. | Small businesses | 1 | $304,838 |
| Luminary Therapeutics, Inc. | Small businesses | 1 | $299,770 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Minnesota?
$323 million from fiscal 2021 to 2025, across 228 awards. Minnesota ranks 17th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Minnesota?
The largest recipient is Regents of the University of Minnesota, with $268 million in 163 awards. Next are Mayo Clinic and Marpam Pharma LLC.
Can organizations in Minnesota apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative